RESUMEN
Bonnecor metabolism in the rat urine was studied. The main metabolites of bonnecor were identified by means of chromatography-mass-spectrometry.
Asunto(s)
Antiarrítmicos/orina , Dibenzazepinas/orina , Animales , Antiarrítmicos/farmacocinética , Biotransformación , Fenómenos Químicos , Química Física , Cromatografía en Capa Delgada , Dibenzazepinas/farmacocinética , Cromatografía de Gases y Espectrometría de Masas , RatasRESUMEN
The pharmacokinetics and pharmacodynamics of bonnecor were studied simultaneously in animals with experimental arrhythmia. It was shown that irrespective of the animal species and individual features of the drug elimination kinetics the level of bonnecor concentration correlated with the antiarrhythmic effect. The data on the excretion of bonnecor and its metabolites in the urine in the dog and man were obtained. The decrease of bioavailability at oral administration of bonnecor was demonstrated to be related to its intensive conversion in metabolite M-I.
Asunto(s)
Antiarrítmicos/farmacocinética , Dibenzazepinas/farmacocinética , Animales , Antiarrítmicos/análisis , Antiarrítmicos/farmacología , Antiarrítmicos/uso terapéutico , Disponibilidad Biológica , Complejos Cardíacos Prematuros/tratamiento farmacológico , Complejos Cardíacos Prematuros/metabolismo , Gatos , Dibenzazepinas/análisis , Dibenzazepinas/farmacología , Dibenzazepinas/uso terapéutico , Perros , Evaluación de Medicamentos , Evaluación Preclínica de Medicamentos , Humanos , Taquicardia/tratamiento farmacológico , Taquicardia/metabolismo , Factores de TiempoRESUMEN
The pharmacokinetics of befol at different routes of administration to animals and humans was studied. The therapeutic level of the drug concentration was established.